CDH2 and breast cancer: Then, we analyzed by western blotting the expression of EMT markers which showed a decrease in the expression of epithelial markers (E-cadherin and occludin) and an increased expression of mesenchymal markers (vimentin and N-cadherin) in Elovl5-silenced breast cancer cells (Fig. 3J, K).